US$ 24.85
bpc-157 human evidence regulatory status fda warning Heal or Harm: Body Protective Compound-157 in the Gray Zone Peptides are having a moment.
Description
One trial involving six courses of Epithalamin over three years demonstrated decelerated cardiovascular aging, preserved physical endurance, normalized circadian melatonin rhythm, and improved carbohydrate and lipid metabolism
Oral BPC-157 (capsules) is an alternative for gut issues (stable in stomach acid per rat studies)
Fosgonimeton is a phosphate prodrug of Dihexa developed by Athira Pharma (formerly M3 Biotechnology)
Since sperm regenerate approximately every three months, we recommend a follow-up test after this period to assess any changes
